NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 31 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2014. The put-call ratio across all filers is 5.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,877,000 | +18670.0% | 545,681 | +7167.0% | 0.00% | – |
| Q2 2015 | $10,000 | – | 7,509 | +1219.7% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 569 | -86.4% | 0.00% | – |
| Q4 2014 | $1,000 | -99.0% | 4,190 | -82.1% | 0.00% | – |
| Q3 2014 | $101,000 | -36.5% | 23,380 | -27.1% | 0.00% | – |
| Q2 2014 | $159,000 | +84.9% | 32,092 | +105.5% | 0.00% | – |
| Q1 2014 | $86,000 | +72.0% | 15,614 | +90.7% | 0.00% | – |
| Q4 2013 | $50,000 | -25.4% | 8,187 | -18.9% | 0.00% | – |
| Q3 2013 | $67,000 | – | 10,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|